Treatment of steroid-resistant acute graft-vs-host disease after allogeneic marrow transplantation with anti-interleukin-2 receptor antibody (BT563). - Hertenstein,B.; Stefanic,M.; Sandherr,M.; Bunjes,D.; Mertens,T.; Arnold,R. (Transplant Proc, 1994)